Mumbai, India , is rapidly emerging as a key hub for the production of Lenacapavir Sodium API (CAS 2189684-53-3). Several organizations have established substantial manufacturing units focusing on this essential antiviral compound. Identifying the definitive top manufacturers can be difficult due